"","Key performance property","Max","NA"
"1","SMC program coverage [70% - 100%]","CLINICAL INCIDENCE","29% to 56%"
"2","SMC program coverage [70% - 100%]","SEVERE DISEASE","53% to 72%"
"3","Duration of protection [10 - 60 days]","CLINICAL INCIDENCE","19% to 48%"
"4","Duration of protection [10 - 60 days]","SEVERE DISEASE","2% to 25%"
"5","SMC round coverage [70% - 100%]","CLINICAL INCIDENCE","14% to 25%"
"6","SMC round coverage [70% - 100%]","SEVERE DISEASE","15% to 29%"
"7","Initial efficacy [80% - 100%]","CLINICAL INCIDENCE","2% to 8%"
"8","Initial efficacy [80% - 100%]","SEVERE DISEASE","0% to 4%"
